ArticleCancer immunology, immunotherapy : CII2018

Chronic lymphocytic leukemia cells acquire regulatory B-cell properties in response to TLR9 and CD40 activation.

Shimrit Ringelstein-Harlev et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.